Fondazione Italiana Diabete Onlus   Report issue

Academic/Hospital Phase 2 Phase 3
Founded: Milan Italy (2009)

Organization Overview

First Clinical Trial
2009
NCT01148446
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2021

Timeline

NOW
  • Now

Alternative names

Ematologia, Candiolo Cancer Institute. FPO-IRCCS | Fondazione Italiana Linfomi ONLUS | Fondazione Italiana Sindromi Mielodisplastiche Onlus